🇺🇸 Insulin lispro (Humalog) in United States

49 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 7 reports (14.29%)
  2. Asthenia — 6 reports (12.24%)
  3. Dyspnoea — 6 reports (12.24%)
  4. Fall — 6 reports (12.24%)
  5. Hypoglycaemia — 6 reports (12.24%)
  6. Cerebrovascular Accident — 4 reports (8.16%)
  7. Diarrhoea — 4 reports (8.16%)
  8. Fatigue — 4 reports (8.16%)
  9. Hyperglycaemia — 3 reports (6.12%)
  10. Hypotension — 3 reports (6.12%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Insulin lispro (Humalog) approved in United States?

Insulin lispro (Humalog) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Insulin lispro (Humalog) in United States?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.